Sun, Mar 1, 2015, 4:02 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

NuPathe Inc. Message Board

fxrdoc 2 posts  |  Last Activity: Jan 9, 2015 12:23 PM Member since: Jan 29, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Bad news today for AMAG is good news for RMTI

    by fxrdoc Jan 9, 2015 12:05 PM
    fxrdoc fxrdoc Jan 9, 2015 12:23 PM Flag

    Their drug was approved a few years ago by the FDA and is their main product. It is an IV iron replacement for chronic kidney disease patients with anemia. We already know it can be toxic and that was discussed at the FDA panel on Triferic. The advantage of Triferic is that it is no more toxic than placebo and can reduce the need for AMAG's iron replacement product by preventing the anemia in the first place. Really good news for RMTI in my opinion.

  • FDA gave AMAG a black box warning for their iron replacement drug for chronic kidney disease. The drug can be very toxic. I believe this supports the very strong probability that FDA approves Triferic given its strong safety profile. Also supports probability that it will dominate the lucrative iron replacement market for chronic kidney disease.

PATH
4.250.00(0.00%)Feb 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
PulteGroup, Inc.
NYSEFri, Feb 27, 2015 4:02 PM EST